{"id":7363,"date":"2026-04-08T11:59:03","date_gmt":"2026-04-08T08:59:03","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=7363"},"modified":"2026-04-08T11:59:04","modified_gmt":"2026-04-08T08:59:04","slug":"ryoncil-duchenne-muscular-dystrophy-trial","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/tr\/ryoncil-duchenne-muscular-dystrophy-trial\/","title":{"rendered":"Duchenne Hastal\u0131\u011f\u0131 \u0130\u00e7in Yeni Umut: Ryoncil Klinik Denemesi Ba\u015fl\u0131yor"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Yeni bir at\u0131l\u0131m, Duchenne kas distrofisinin gelece\u011fini de\u011fi\u015ftirebilir. <strong>Yeni bir h\u00fccre terapisi olan Ryoncil (remestemcel-L-rknd), \u00f6nemli bir klinik deneme i\u00e7in FDA onay\u0131n\u0131 ald\u0131.<\/strong> \u0130ltihab\u0131 hedef alarak, \u00e7ocuklarda hastal\u0131\u011f\u0131n ilerlemesini yava\u015flatmay\u0131 ve kas fonksiyonunu korumay\u0131 ama\u00e7lamaktad\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Duchenne kas distrofisi (DMD), kaslar\u0131n zamanla zay\u0131flamas\u0131na neden olan ciddi bir genetik hastal\u0131kt\u0131r. \u00c7o\u011funlukla gen\u00e7 erkek \u00e7ocuklar\u0131 etkiler ve yaln\u0131zca Amerika Birle\u015fik Devletleri'nde yakla\u015f\u0131k 15.000 \u00e7ocuk bu rahats\u0131zl\u0131kla ya\u015famaktad\u0131r. Tedaviler mevcut olsa da, hen\u00fcz kesin bir tedavisi bulunmamaktad\u0131r; bu da yeni ara\u015ft\u0131rmalar\u0131 son derece \u00f6nemli k\u0131lmaktad\u0131r. Daha Fazlas\u0131n\u0131 Okuyun: <a href=\"https:\/\/dmdwarrior.com\/tr\/what-is-duchenne\/\" target=\"_blank\" rel=\"noreferrer noopener\">Duchenne Nedir?<\/a><\/p>\n\n\n\n<div class=\"wp-block-rank-math-toc-block\" id=\"rank-math-toc\"><h2>\u0130\u00e7indekiler<\/h2><nav><ul><li><a href=\"#a-promising-update-from-mesoblast\">Mesoblast&#039;den Umut Verici Bir G\u00fcncelleme<\/a><\/li><li><a href=\"#what-is-ryoncil\">Ryoncil nedir?<\/a><\/li><li><a href=\"#what-is-stromal-cell-therapy\">Stromal H\u00fccre Tedavisi Nedir?<\/a><\/li><li><a href=\"#why-is-this-important-for-dmd\">Bu, DMD i\u00e7in neden \u00f6nemli?<\/a><\/li><li><a href=\"#details-of-the-new-clinical-trial\">Yeni Klinik \u00c7al\u0131\u015fman\u0131n Detaylar\u0131<\/a><\/li><li><a href=\"#collaboration-with-the-dmd-community\">DMD Toplulu\u011fu ile \u0130\u015fbirli\u011fi<\/a><\/li><li><a href=\"#expert-perspective\">Uzman Bak\u0131\u015f A\u00e7\u0131s\u0131<\/a><\/li><li><a href=\"#looking-ahead\">Gelece\u011fe Bak\u0131\u015f<\/a><\/li><li><a href=\"#frequently-asked-questions\">S\u0131k\u00e7a Sorulan Sorular<\/a><ul><li><a href=\"#faq-question-1775637412256\">Ryoncil (remestemcel-L-rknd) nedir?<\/a><\/li><li><a href=\"#faq-question-1775637420488\">Ryoncil tedavisi Duchenne kas distrofisi (DMD) i\u00e7in onaylanm\u0131\u015f m\u0131d\u0131r?<\/a><\/li><li><a href=\"#faq-question-1775637445677\">Ryoncil, DMD&#039;li \u00e7ocuklara nas\u0131l yard\u0131mc\u0131 olabilir?<\/a><\/li><li><a href=\"#faq-question-1775637456639\">Klinik ara\u015ft\u0131rmaya kimler kat\u0131labilir?<\/a><\/li><li><a href=\"#faq-question-1775637478029\">Bu klinik deneme neden \u00f6nemli?<\/a><\/li><li><a href=\"#faq-question-1775637485859\">Ryoncil g\u00fcvenli mi?<\/a><\/li><li><a href=\"#faq-question-1775637492047\">Ryoncil hastalara nas\u0131l verilir?<\/a><\/li><li><a href=\"#faq-question-1775637508773\">Sonu\u00e7lar ne zaman a\u00e7\u0131klanacak?<\/a><\/li><\/ul><\/li><li><a href=\"#final-thoughts\">Son D\u00fc\u015f\u00fcnceler<\/a><\/li><\/ul><\/nav><\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"a-promising-update-from-mesoblast\">Mesoblast&#039;den Umut Verici Bir G\u00fcncelleme<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Biyoteknoloji \u015firketi Mesoblast, ABD G\u0131da ve \u0130la\u00e7 \u0130daresi&#039;nden (FDA) \u00f6nemli bir onay ald\u0131 (FDA).<\/strong> Bu onay, \u015firketin Ryoncil\u00ae adl\u0131 tedavisi i\u00e7in do\u011frudan ileri a\u015fama klinik denemeye (kay\u0131t denemesi olarak adland\u0131r\u0131l\u0131r) ge\u00e7mesine olanak tan\u0131yor.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bu t\u00fcr bir deneme b\u00fcy\u00fck bir ad\u0131md\u0131r. Ba\u015far\u0131l\u0131 olursa, Ryoncil&#039;nin DMD&#039;li \u00e7ocuklar\u0131n tedavisi i\u00e7in resmi olarak onaylanmas\u0131na yol a\u00e7abilir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"what-is-ryoncil\">Ryoncil nedir?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ryoncil, mezenkimal stromal h\u00fccreler (MSC&#039;ler) olarak bilinen \u00f6zel don\u00f6r h\u00fccrelerden elde edilen h\u00fccre bazl\u0131 bir terapidir.<\/strong> Bu h\u00fccreler v\u00fccuttaki iltihab\u0131 kontrol etmeye yard\u0131mc\u0131 olmak \u00fczere tasarlanm\u0131\u015ft\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bu tedavi, \u00e7ocuklarda g\u00f6r\u00fclen ve greft-konak\u00e7\u0131 hastal\u0131\u011f\u0131 (GVHD) olarak adland\u0131r\u0131lan farkl\u0131 bir ciddi rahats\u0131zl\u0131k i\u00e7in FDA taraf\u0131ndan zaten onaylanm\u0131\u015ft\u0131r; bu da ara\u015ft\u0131rmac\u0131lara tedavinin g\u00fcvenli\u011fi konusunda g\u00fcven vermektedir. Daha fazla bilgi i\u00e7in: <a href=\"https:\/\/investorsmedia.mesoblast.com\/static-files\/0c792a74-45f1-4b6f-b082-974bcb78f7c2\" target=\"_blank\" rel=\"noopener\">Mesoblast'\u0131n Ryoncil'i, ABD FDA taraf\u0131ndan onaylanan ilk mezenkimal stromal h\u00fccre (MSC) terapisidir.<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"what-is-stromal-cell-therapy\">Stromal H\u00fccre Tedavisi Nedir?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Stromal h\u00fccre tedavisi, iltihab\u0131 azaltmak, hasarl\u0131 dokuyu onarmak ve ba\u011f\u0131\u015f\u0131kl\u0131k sistemini d\u00fczenlemek i\u00e7in mezenkimal stromal h\u00fccreler (MSC&#039;ler) ad\u0131 verilen \u00f6zel destek h\u00fccrelerini kullanan bir t\u00fcr rejeneratif t\u0131p y\u00f6ntemidir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"why-is-this-important-for-dmd\">Bu, DMD i\u00e7in neden \u00f6nemli?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>DMD&#039;deki temel sorunlardan biri, zamanla kas dokusuna zarar veren kronik iltihaplanmad\u0131r.<\/strong> Ara\u015ft\u0131rmac\u0131lar, bu iltihab\u0131 azaltman\u0131n \u015funlara yol a\u00e7abilece\u011fine inan\u0131yor:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Kaslar\u0131 korumaya yard\u0131mc\u0131 olur<\/li>\n\n\n\n<li>Hastal\u0131\u011f\u0131n ilerlemesini yava\u015flat\u0131r<\/li>\n\n\n\n<li>G\u00fcc\u00fc daha uzun s\u00fcre korur<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Ryoncil, ba\u011f\u0131\u015f\u0131kl\u0131k sistemini sakinle\u015ftirerek \u00e7al\u0131\u015f\u0131r ve bu da zararl\u0131 iltihab\u0131 azaltabilir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"details-of-the-new-clinical-trial\">Yeni Klinik \u00c7al\u0131\u015fman\u0131n Detaylar\u0131<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Yakla\u015fan \u00e7al\u0131\u015fma \u015funlar\u0131 i\u00e7erecektir:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>5 ila 9 ya\u015f aras\u0131 76 \u00e7ocuk<\/strong><\/li>\n\n\n\n<li>Kat\u0131l\u0131mc\u0131lara \u015fu se\u00e7eneklerden biri sunulacakt\u0131r:\n<ul class=\"wp-block-list\">\n<li>Ryoncil (9 ay boyunca birden fazla inf\u00fczyon yoluyla) veya<\/li>\n\n\n\n<li>Plasebo (etkisiz tedavi)<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li>T\u00fcm \u00e7ocuklar standart bak\u0131m almaya devam edecek.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ana ama\u00e7, \u00e7ocuklar\u0131n yerden ne kadar \u00e7abuk kalkabildiklerini \u00f6l\u00e7mektir; bu da kas fonksiyonu ve hastal\u0131k ilerlemesi a\u00e7\u0131s\u0131ndan \u00f6nemli bir g\u00f6stergedir.<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"collaboration-with-the-dmd-community\">DMD Toplulu\u011fu ile \u0130\u015fbirli\u011fi<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Mesoblast, \u00f6nde gelen hasta haklar\u0131 savunuculu\u011fu kurulu\u015fu olan Parent Project Muscular Dystrophy (PPMD) ile yak\u0131n i\u015fbirli\u011fi i\u00e7inde \u00e7al\u0131\u015fmaktad\u0131r. Bu ortakl\u0131\u011f\u0131n ama\u00e7lar\u0131 \u015funlard\u0131r:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ailelerin klinik deneme hakk\u0131nda bilgi edinmelerine yard\u0131mc\u0131 olmak<\/li>\n\n\n\n<li>Hasta kat\u0131l\u0131m\u0131n\u0131 desteklemek<\/li>\n\n\n\n<li>DMD toplulu\u011fu i\u00e7inde fark\u0131ndal\u0131\u011f\u0131 art\u0131rmak<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"expert-perspective\">Uzman Bak\u0131\u015f A\u00e7\u0131s\u0131<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">\u00c7al\u0131\u015fmaya kat\u0131lan doktorlar umutlu. Kaslar hala nispeten g\u00fc\u00e7l\u00fcyken iltihab\u0131 erken a\u015famada hedeflemenin, hastal\u0131\u011f\u0131n geli\u015fiminde anlaml\u0131 bir fark yaratabilece\u011fine inan\u0131yorlar.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"looking-ahead\">Gelece\u011fe Bak\u0131\u015f<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Bu tedavi hen\u00fcz ara\u015ft\u0131rma a\u015famas\u0131nda olsa da, ileri a\u015fama denemelere h\u0131zla ge\u00e7mesi cesaret verici. Bu durum, ara\u015ft\u0131rmac\u0131lar\u0131n Ryoncil'i DMD ile ya\u015fayan \u00e7ocuklara yard\u0131mc\u0131 olman\u0131n yeni bir yolu olarak ger\u00e7ek bir potansiyel olarak g\u00f6rd\u00fcklerini g\u00f6steriyor.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"frequently-asked-questions\">S\u0131k\u00e7a Sorulan Sorular<\/h2>\n\n\n<div id=\"rank-math-faq\" class=\"rank-math-block\">\n<div class=\"rank-math-list\">\n<div id=\"faq-question-1775637412256\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Ryoncil (remestemcel-L-rknd) nedir?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Ryoncil, Mesoblast taraf\u0131ndan geli\u015ftirilen h\u00fccre bazl\u0131 bir terapidir. V\u00fccuttaki iltihab\u0131 azaltmaya yard\u0131mc\u0131 olmak i\u00e7in \u00f6zel don\u00f6r h\u00fccreler kullan\u0131r.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1775637420488\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Ryoncil tedavisi Duchenne kas distrofisi (DMD) i\u00e7in onaylanm\u0131\u015f m\u0131d\u0131r?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Hay\u0131r, Ryoncil hen\u00fcz DMD i\u00e7in onaylanmad\u0131. \u015eu anda ileri a\u015fama bir klinik denemede test ediliyor.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1775637445677\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Ryoncil, DMD&#039;li \u00e7ocuklara nas\u0131l yard\u0131mc\u0131 olabilir?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Ryoncil, DMD&#039;de kaslara zarar veren \u00f6nemli bir fakt\u00f6r olan iltihab\u0131 azaltarak hastal\u0131\u011f\u0131n ilerlemesini yava\u015flatmaya yard\u0131mc\u0131 olabilir.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1775637456639\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Klinik ara\u015ft\u0131rmaya kimler kat\u0131labilir?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>\u00c7al\u0131\u015fmaya, Duchenne kas distrofisi olan ve belirli t\u0131bbi kriterleri kar\u015f\u0131layan 5 ila 9 ya\u015f aras\u0131 \u00e7ocuklar dahil ediliyor.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1775637478029\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Bu klinik deneme neden \u00f6nemli?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Bu bir kay\u0131t denemesi olup, ba\u015far\u0131l\u0131 sonu\u00e7lar Ryoncil'in DMD tedavisi olarak resmi onay\u0131na yol a\u00e7abilir.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1775637485859\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Ryoncil g\u00fcvenli mi?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Ryoncil, \u00e7ocuklarda g\u00f6r\u00fclen bir di\u011fer ciddi hastal\u0131k i\u00e7in zaten onaylanm\u0131\u015f olup, bu da g\u00fc\u00e7l\u00fc g\u00fcvenlik verileri sa\u011flamaktad\u0131r; ancak DMD i\u00e7in de\u011ferlendirme s\u00fcreci devam etmektedir.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1775637492047\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Ryoncil hastalara nas\u0131l verilir?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Klinik denemenin bir par\u00e7as\u0131 olarak, birka\u00e7 ay boyunca damar yoluyla inf\u00fczyon \u015feklinde uygulan\u0131r.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1775637508773\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Sonu\u00e7lar ne zaman a\u00e7\u0131klanacak?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Klinik ara\u015ft\u0131rmalar zaman al\u0131r, ancak \u00e7al\u0131\u015fma tamamlan\u0131p analiz edildikten sonra sonu\u00e7lar\u0131n al\u0131nmas\u0131 beklenir.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"final-thoughts\">Son D\u00fc\u015f\u00fcnceler<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Ryoncil, Duchenne kas distrofisinin tedavisinde farkl\u0131 bir yakla\u015f\u0131m\u0131 temsil ediyor; genetik nedeni do\u011frudan hedeflemek yerine iltihab\u0131 azaltmaya odaklan\u0131yor. Yakla\u015fan deneme ba\u015far\u0131l\u0131 olursa, hastal\u0131\u011f\u0131n ilerlemesini yava\u015flatmaya ve bir\u00e7ok \u00e7ocu\u011fun ya\u015fam kalitesini iyile\u015ftirmeye yard\u0131mc\u0131 olacak yeni bir tedavi se\u00e7ene\u011finin \u00f6n\u00fcn\u00fc a\u00e7abilir.<\/p>","protected":false},"excerpt":{"rendered":"<p>A new breakthrough may change the future of Duchenne muscular dystrophy. Ryoncil (remestemcel-L-rknd), a novel cell therapy, has received FDA clearance for a key clinical trial. By targeting inflammation, it aims to slow disease progression and protect muscle function in children. Duchenne muscular dystrophy (DMD) is a serious genetic disease that causes muscles to weaken [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":7365,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[413,647,645,649,644,646,648],"class_list":["post-7363","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-dmd-clinical-trials","tag-inflammation-in-dmd","tag-mesoblast","tag-remestemcel-l","tag-ryoncil","tag-sr-agvhd","tag-stromal-cell-therapy"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/7363","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/comments?post=7363"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/7363\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media\/7365"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media?parent=7363"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/categories?post=7363"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/tags?post=7363"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}